English | Español
Patient Daily | Mar 30, 2026

Sarepta reports early promise for RNA therapies after gene therapy setbacks
Patient Daily | Mar 30, 2026

FDA grants accelerated approval to Denali’s Avlayah for Hunter syndrome
Patient Daily | Mar 30, 2026

Beam Therapeutics reports positive data for base editor in alpha-1 antitrypsin deficiency
Patient Daily | Mar 30, 2026

BioSpace survey finds leadership more likely than managers to drive employee departures
Patient Daily | Mar 30, 2026

Maze Therapeutics shares fall after mixed results in kidney disease drug trial
Patient Daily | Mar 30, 2026

Indiana life sciences industry reports growth and new investments in 2026
Patient Daily | Mar 30, 2026

Wave Life Sciences shares fall after higher dose obesity trial data disappoints analysts
Patient Daily | Mar 30, 2026

University of Chicago and IDefine launch research program to develop Kleefstra syndrome treatment

Trending
+ Regulatory
A. D. Alderman | Jun 11, 2026

Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'
+ Regulatory
A. D. Ahrens | Jun 11, 2026

Economist: 'The 340B program has been hijacked by tax-exempt hospitals'
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Regulatory
Patient Daily | Jun 12, 2026

Taxpayer advocate: 340B drug discount program offers 'perverse incentives'